DIABETIC DYSLIPIDEMIA AND ATHEROSCLEROSIS

被引:0
作者
SHEPHERD, J
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non insulin-dependent diabetes mellitus is frequently accompanied by qualitative and quantitative abnormalities in plasma lipids and lipoproteins, Increased triglycerides and decreased HDL (high density lipoprotein)-cholesterol are commonly observed; these alterations are recognized risk factors for coronary heart disease. Moderately elevated plasma triglyceride-rich liproproteins may contribute to the atherogenic process through remodelling of LDL (low density liproprotein) and HDL particles. Good glycemic control, diet and, when necessary, treatment with fibrates will correct or partially reverse the abnormal lipoprotein profiles found in diabetic patients.
引用
收藏
页码:1933 / 1937
页数:5
相关论文
共 50 条
  • [41] DYSLIPIDEMIA AND ATHEROSCLEROSIS - A FORECAST OF PHARMACEUTICAL APPROACHES
    GOTTO, AM
    CIRCULATION, 1993, 87 (04) : 54 - 59
  • [42] Establishment of an Atherosclerosis and Dyslipidemia Program in Kazakhstan
    Bekbossynova, Makhabbat
    Ivanova-Razumova, Tatiana
    Ablayeva, Ayana
    Oralbekova, Zhansaya
    MAYO CLINIC PROCEEDINGS, 2024, 99 (11) : 1698 - 1701
  • [43] Coronary distensibility is impaired in diabetic dyslipidemia before overt atherosclerosis and segmental variation is identifiable by intravascular ultrasound
    Zafar, MN
    Reddy, HK
    Mokelke, E
    Sturek, M
    CIRCULATION, 2003, 108 (17) : 463 - 463
  • [44] Diabetic dyslipidemia: evaluation and mechanism
    Yanai, Hidekatsu
    Hirowatari, Yuji
    Yoshida, Hiroshi
    GLOBAL HEALTH & MEDICINE, 2019, 1 (01): : 30 - 35
  • [45] Pharmacological management of diabetic dyslipidemia
    Filippatos, T. D.
    Florentin, M.
    Georgoula, M.
    Elisaf, M. S.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (02) : 187 - 200
  • [46] DYSLIPIDEMIA OF DIABETIC-PATIENTS
    BRUN, JM
    DROUIN, P
    BERTHEZENE, F
    JACOTOT, B
    POMETTA, D
    DIABETES & METABOLISM, 1995, 21 (01): : 59 - 62
  • [47] Pathogenesis and significance of diabetic dyslipidemia
    Parhofer, K. G.
    Wu, Liya
    DIABETOLOGE, 2019, 15 (01): : 7 - 12
  • [48] Dyslipidemia in hypertensive diabetic patients
    Azgaou, I.
    El Mghari, G.
    El Ansari, N.
    DIABETES & METABOLISM, 2012, 38 : A123 - A123
  • [49] MANAGEMENT OF DYSLIPIDEMIA IN DIABETIC NEPHROPATHY
    Mamasakhlisi, A.
    ATHEROSCLEROSIS, 2020, 315 : E264 - E264
  • [50] Diabetic dyslipidemia or 'diabetes lipidus'?
    Muacevic-Katanec, Diana
    Reiner, Zeljko
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2011, 9 (03) : 341 - 348